Description
Tesamorelin 11mg + Ipamorelin 6mg Blend (17mg Total) — Lyophilized Research Peptide
Tesamorelin 11mg + Ipamorelin 6mg is a blended, lyophilized peptide vial designed for research exploring
GH/IGF-1 axis signaling, pituitary secretory dynamics, and endocrine-related biomarker readouts. Each vial contains
17mg total (11mg Tesamorelin + 6mg Ipamorelin) with ≥99% purity and a lot-specific COA available.
This Tesamorelin + Ipamorelin blend is commonly referenced in laboratory settings as a GHRH-analog + growth hormone
secretagogue research combination. Investigators use these peptides as tools to study endocrine feedback loops,
hormone signaling pathways, and downstream metabolic markers under controlled experimental conditions.
What It Is
- Class: Synthetic peptide blend (GHRH analog + growth-hormone secretagogue)
- Research purpose: Used as an experimental tool for studying GH pulsatility, GH/IGF-1 axis activity, and endocrine signaling pathways.
- Common lab readouts: Hormone signaling markers, gene/protein expression panels, and endocrine/metabolic biomarker tracking (model-dependent).
Proposed Mechanisms & Pathways (Preclinical)
GH Release Signaling
- Tesamorelin: Studied for activation of GHRH-receptor pathways in models assessing pituitary signaling and GH-related readouts.
- Ipamorelin: Investigated for activity in growth-hormone secretagogue signaling (often referenced alongside ghrelin/GHSR-related research).
- Blended preparations are used to explore complementary signaling related to secretion dynamics and feedback regulation in controlled experiments.
Downstream Biomarkers & System Readouts
- GH-linked pathways are frequently tracked via IGF-1–related measurements and downstream pathway markers (assay/model dependent).
- Research designs may include metabolic panels and body-composition proxy markers, depending on the study system and endpoints.
- Often used in mechanistic endocrine research to compare GHRH-pathway signaling vs. secretagogue-pathway signaling effects on downstream readouts.
Selected Research Highlights
- GH/IGF-1 Axis: Used to probe pituitary output patterns and downstream signaling cascades associated with GH biology.
- Endocrine Feedback: Included in research examining hormone feedback regulation and secretory dynamics.
- Metabolic Biomarkers: Utilized in controlled models measuring endocrine-linked metabolic readouts alongside pathway markers.
Chemical & Handling Information
- Type: Lyophilized peptide blend (Tesamorelin + Ipamorelin)
- Appearance: White to off-white lyophilized powder (hygroscopic; handle promptly)
- General handling: Protect from moisture, excessive heat, and light during routine laboratory handling.
Storage & Stability
- Store lyophilized vials in a cool, dry place, protected from light and moisture.
- Refrigeration or freezing of the lyophilized material is recommended for extended stability, according to laboratory SOPs.
- After reconstitution, store at 2–8 °C for short-term use.
- For longer-term storage, aliquot and freeze at ?20 °C or below; avoid repeated freeze–thaw cycles.
FAQ
What is the vial content and total amount?
Each vial contains 17mg total: Tesamorelin 11mg + Ipamorelin 6mg in lyophilized powder form.
Is a COA available?
Yes—purity is listed as ≥99% (HPLC) with a COA available per lot. You can link users to your Lab Tests page.
How should the material be stored?
Store dry vials in a cool, dry place. After reconstitution, refrigerate 2–8 °C short-term or freeze ?20 °C for long-term storage (avoid repeated freeze–thaw cycles).
Research use only. Not for human or veterinary use. For Tesamorelin + Ipamorelin blended research vials, visit
MyPurePeptide.com.
Reviews
There are no reviews yet.